Home > Boards > US Listed > Medical - Healthcare >

Acasti Pharma, Inc (ACST)

ACST RSS Feed
Add ACST Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 10/18/2019 5:45:21 PM - Followers: 58 - Board type: Free - Posts Today: 0

Acasti Pharma is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre®, for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one-third of the U.S. population.

Established in August 2008, Acasti is focused on addressing an important market need for an effective, safe and well-absorbed omega-3 therapeutic that can address a patient’s lipid profile — making a positive impact on the major lipids associated with cardiovascular disease risk.


 
 


President and CEO 
Jan D'Alvise
LinkedIn


 

Acasti’s Phase 3-ready investigational candidate CaPre® will be the first pharmaceutical omega-3 product sourced from krill oil. CaPre® has successfully completed phase 1 and 2 trials for the treatment of hypertriglyceridemia, a common metabolic condition characterized by high levels of triglycerides in the blood stream.

The American Heart Association has estimated that one-third of the U.S. population has elevated levels of triglycerides.

 

CaPre’s concentrated omega-3s from krill oil are absorbed into the body more efficiently than those from fish oils, enhancing bioavailability and providing benefits to a patient’s total lipid profile. That means that CaPre® doesn’t just lower triglycerides; it also has shown in clinical trials to have beneficial effects on “good” and “bad” cholesterol levels that affect heart health.
 


Laval, Québec, CANADA, Sept. 14, 2016 Acasti Pharma (NASDAQ:ACST TSX-V:APO) today announced that its bridging study for novel drug candidate CaPre® (omega-3 phospholipid) has successfully met its objectives, supporting Acasti’s strategy to pursue the U.S. Food and Drug Administration’s (FDA) 505(b)(2) regulatory pathway for approval. Acasti is developing CaPre for the treatment of patients with severe hypertriglyceridemia, a metabolic condition that contributes to increased risk of cardiovascular disease and pancreatitis. The 505(b)(2) regulatory pathway allows Acasti to streamline the overall development program required to support a New Drug Application (NDA) by relying on the safety data of an approved drug. 



Laval, Québec, CANADA, October 26, 2016 — Acasti Pharma (NASDAQ:ACST TSX-V:APO) today announced that the United States Patent and Trademark Office issued Acasti a patent (U.S. patent no. 9,475,830) directed to a method of treating hypertriglyceridemia by the administration of a concentrated phospholipid composition. 
This newly issued patent expands Acasti’s intellectual property portfolio related to concentrated therapeutic phospholipid omega-3 compositions covering methods for treating or preventing diseases associated with or related to cardiovascular disease. 

 
 


 







ACST
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ACST News: Report of Foreign Issuer (6-k) 10/01/2019 09:01:17 AM
ACST News: Report of Foreign Issuer (6-k) 09/30/2019 08:37:48 AM
ACST News: Acasti Pharma Announces Additional Phase 3 Milestones Reached, and Remains on Track to Report Topline Results for TRILOGY 1 i... 09/30/2019 08:35:00 AM
ACST News: Report of Foreign Issuer (6-k) 09/09/2019 08:42:19 AM
ACST News: Acasti Pharma Receives Funding from the Government of Canada to Expand Production Capacity 09/09/2019 08:30:00 AM
PostSubject
#537   * * $ACST Video Chart 10-18-2019 * * ClayTrader 10/18/19 05:45:21 PM
#536   Hey all. Is ACST debt-free, or close? UFO 09/17/19 09:34:08 AM
#535   ACST getting cont'd support from Canadian govt: value1008 09/09/19 08:43:05 AM
#534   Anyone going to this? ACST - Acasti Pharma Eagle1 09/08/19 02:39:25 PM
#533   ACST: $2.15 This has a very nice Eagle1 09/08/19 02:35:24 PM
#532   UFO - valuation could take off if secondary awalkinthesun 09/04/19 02:44:39 PM
#531   CDrucker - previous phase 2 covered a lower awalkinthesun 09/04/19 02:13:06 PM
#530   News: $ACST Acasti Pharma to Present at the whytestocks 09/04/19 01:30:26 PM
#529   ACST looks pretty bullish here 1.88. risk is deadjim 08/30/19 01:11:27 PM
#528   What will be ACST patient population? They CDrucker 08/30/19 07:46:58 AM
#527   With killer top-line numbers? $40-$50 a share. UFO 08/29/19 12:20:13 PM
#526   Where do you see this in Dec/Jan with speedstar 08/29/19 11:26:45 AM
#525   Did $ACST "finally" find a bottom? Hammer UFO 08/29/19 11:15:59 AM
#524   * * $ACST Video Chart 08-14-2019 * * ClayTrader 08/14/19 05:58:30 PM
#523   News: $ACST Acasti Pharma Provides Business Update for whytestocks 08/14/19 02:40:24 PM
#522   * * $ACST Video Chart 08-05-2019 * * ClayTrader 08/05/19 05:44:59 PM
#521   hey clay, jammastermike 08/02/19 09:12:55 PM
#520   no problem... have a good weekend ClayTrader 08/02/19 05:34:09 PM
#519   Spare me wodehouse 08/02/19 05:31:47 PM
#518   Hanging out with you. ClayTrader 08/02/19 05:24:24 PM
#517   What are you doing here? wodehouse 08/02/19 05:20:41 PM
#516   * * $ACST Video Chart 07-31-2019 * * ClayTrader 07/31/19 04:22:01 PM
#515   Wow, when the 2.58-61 area held up the value1008 07/31/19 02:38:07 PM
#514   Consolidation day. No stock goes straight up, though value1008 07/31/19 10:38:31 AM
#513   Why the sudden drop today ? Asdeqwe 07/31/19 10:13:48 AM
#512   “We are significantly increasing our US sales estimates crudeoil24 07/31/19 09:22:10 AM
#511   Uddin says no other drug or drug candidate crudeoil24 07/31/19 09:20:49 AM
#510   Chen Maggadino is buying ACST. crudeoil24 07/31/19 09:11:31 AM
#509   What is Chen Buying? What is Chen Selling? JB3729 07/31/19 08:35:52 AM
#508   Looking great Eagle1 07/30/19 08:17:58 PM
#507   Let's keep rolling we may be better than Pyramid2 07/30/19 05:39:17 PM
#506   thx value! jammastermike 07/30/19 04:48:50 PM
#505   Hey Mike, i already discussed this briefly last value1008 07/30/19 04:44:37 PM
#504   value, thanks for the insight. how do you jammastermike 07/30/19 04:35:56 PM
#503   Yes! > 2.93 now, soon $3.00+ new hod's. crudeoil24 07/30/19 12:30:19 PM
#502   These guys like Haywood keep a lot of value1008 07/30/19 11:55:52 AM
#501   "Haywood has continued to add to his position crudeoil24 07/30/19 09:08:29 AM
#500   ACST is a great $$$$$ opportunity. crudeoil24 07/30/19 09:06:19 AM
#499   This article appeared on Seeking Alpha. Is Acasti crudeoil24 07/30/19 09:04:48 AM
#498   * * $ACST Video Chart 07-29-2019 * * ClayTrader 07/29/19 05:27:07 PM
#497   I like what I read on the link, speedstar 07/29/19 01:11:04 PM
#496   Thanks for the link! value1008 07/28/19 05:36:00 PM
#495   New article posted by Blair on ymb: Keith27 07/28/19 04:20:12 PM
#494   I'm actually finding Clay's 30-min charts to be value1008 07/26/19 10:47:13 PM
#493   stupid video charts LOL! wodehouse 07/26/19 06:07:33 PM
#492   * * $ACST Video Chart 07-26-2019 * * ClayTrader 07/26/19 05:36:46 PM
#491   ACST stock needed to rest, breathe, consolidate.... It value1008 07/26/19 01:56:02 PM
#490   What do you think is causing the sudden Skipman6 07/26/19 01:52:51 PM
#489   I agree with that 100% and I am ridinbulls 07/25/19 08:34:58 AM
#488   Yeah-- the truth is that everyone who looks value1008 07/25/19 08:31:13 AM
PostSubject